RecruitingNCT05598879

Global Cardio Oncology Registry

Sponsor

The Cleveland Clinic

Enrollment

5,000 participants

Start Date

Jul 1, 2022

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Cardiotoxicity Cardiovascular Diseases Hematologic Malignancy Immune Checkpoint Inhibitor-Related Myocarditis

Summary

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This global registry collects data on cancer patients who also develop heart problems — a field known as cardio-oncology. Cancer treatments like chemotherapy and immunotherapy can affect the heart, and this registry tracks those effects in the real world. **You may be eligible if...** - You have breast cancer, lymphoma (Hodgkin's or non-Hodgkin's), leukemia, multiple myeloma, or a related blood cancer - You are being seen for the first time in a cardio-oncology clinic (a clinic that manages both heart and cancer care) - You are receiving or have received cancer treatments that can affect the heart, such as immune checkpoint inhibitors or HER2-targeted therapy **You may NOT be eligible if...** - You have not had a new cardio-oncology consultation - You have a cancer type not included in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERanonymized data collection during programmed surveillance clinical follow up

anonymized data entry of demographic, clinical, imaging, laboratory, cancer treatment, and cardiovascular events into a RedCap Cloud platform

Locations(1)

Cleveland Clinic Florida

Weston, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05598879

Related Trials

Diabetes and Heart Disease Risk in Blacks

NCT000018531 location

Genomic Services Research Program

NCT025959571 location

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT068852031 location

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NCT06103864316 locations